These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 2896298

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH, Hooks JJ, Quinnan GV, Lane HC, Manischewitz JF, Macher AM, Masur H, Fauci AS, Djeu JY.
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [Abstract] [Full Text] [Related]

  • 3. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.
    J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
    Ueno Y, Miyawaki T, Seki H, Matsuda A, Taga K, Sato H, Taniguchi N.
    J Immunol; 1985 Jul 15; 135(1):180-4. PubMed ID: 3923100
    [Abstract] [Full Text] [Related]

  • 5. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
    Itoh K, Shiiba K, Shimizu Y, Suzuki R, Kumagai K.
    J Immunol; 1985 May 15; 134(5):3124-9. PubMed ID: 2984283
    [Abstract] [Full Text] [Related]

  • 6. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec 15; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 7. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma.
    Pène J, Rousset F, Brière F, Chrétien I, Paliard X, Banchereau J, Spits H, De Vries JE.
    J Immunol; 1988 Aug 15; 141(4):1218-24. PubMed ID: 3135324
    [Abstract] [Full Text] [Related]

  • 8. The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system.
    Nakagawa N, Nakagawa T, Volkman DJ, Ambrus JL, Fauci AS.
    J Immunol; 1987 Feb 01; 138(3):795-801. PubMed ID: 3100616
    [Abstract] [Full Text] [Related]

  • 9. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
    Siegel JP, Djeu JY, Stocks NI, Masur H, Gelmann EP, Quinnan GV.
    J Clin Invest; 1985 Jun 01; 75(6):1957-64. PubMed ID: 2989337
    [Abstract] [Full Text] [Related]

  • 10. Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations.
    Thurman GB, Maluish AE, Rossio JL, Schlick E, Onozaki K, Talmadge JE, Procopio AD, Ortaldo JR, Ruscetti FW, Stevenson HC.
    J Biol Response Mod; 1986 Feb 01; 5(1):85-107. PubMed ID: 3514800
    [Abstract] [Full Text] [Related]

  • 11. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
    Lotz M, Tsoukas CD, Fong S, Dinarello CA, Carson DA, Vaughan JH.
    J Immunol; 1986 May 15; 136(10):3636-42. PubMed ID: 3009608
    [Abstract] [Full Text] [Related]

  • 12. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H, Seki S, Habu Y, Ohkawa T, Takeshita S, Hiraide H, Sekine I.
    Hepatology; 1999 Aug 15; 30(2):430-6. PubMed ID: 10421651
    [Abstract] [Full Text] [Related]

  • 13. Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2.
    Burdach S, Shatsky M, Wagenhorst B, Levitt L.
    J Immunol; 1987 Jul 15; 139(2):452-8. PubMed ID: 3110272
    [Abstract] [Full Text] [Related]

  • 14. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies.
    Hanenberg H, Dilloo D, Laws HJ, Zessack N, Heyll A, Burdach S.
    Exp Hematol; 1995 Dec 15; 23(14):1543-52. PubMed ID: 8542945
    [Abstract] [Full Text] [Related]

  • 15. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.
    Iho S, Yamamoto T, Takahashi T, Yamamoto S.
    J Immunol; 1999 Oct 01; 163(7):3642-52. PubMed ID: 10490958
    [Abstract] [Full Text] [Related]

  • 16. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM, Vilcek J.
    J Immunol; 1987 Nov 15; 139(10):3330-7. PubMed ID: 3119705
    [Abstract] [Full Text] [Related]

  • 17. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 15; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4.
    Yu CR, Kirken RA, Malabarba MG, Young HA, Ortaldo JR.
    J Immunol; 1998 Jul 01; 161(1):218-27. PubMed ID: 9647227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.